-
EP2460817
European procedure
Extract from the Register of European Patents
EP About this file: EP2460817
| EP2460817 - PCV2 immunogenic compositions and methods of producing such compositions [Right-click to bookmark this link] | Status | Patent revoked Status updated on 18.03.2022 Database last updated on 03.04.2025 | |
| Former | The patent has been granted Status updated on 24.02.2017 | ||
| Former | Grant of patent is intended Status updated on 01.02.2017 | ||
| Former | Examination is in progress Status updated on 17.01.2017 | ||
| Former | Grant of patent is intended Status updated on 13.12.2016 | Most recent event Tooltip | 19.04.2024 | Lapse of the patent in a contracting state | published on 22.05.2024 [2024/21] | Applicant(s) | For all designated states Boehringer Ingelheim Animal Health USA Inc. 3239 Satellite Blvd Duluth, GA 30096 / US | [2019/19] |
| Former [2012/23] | For all designated states Boehringer Ingelheim Vetmedica, Inc. 2621 North Belt Highway St. Joseph, MO 64506-2002 / US | Inventor(s) | 01 /
Eichmeyer, Mark Boehringer Ingelheim Vetmedica, Inc. 2621 North Belt Highway St. Joseph, MO 64506-2002 / US | 02 /
Nitzel, Greg Boehringer Ingelheim Vetmedica, Inc. 2621 North Belt Highway St. Joseph, MO 64506-2002 / US | 03 /
Schaeffer, Merrill Boehringer Ingelheim Vetmedica , Inc. 2621 North Belt Highway St. Joseph, MO 64506-2002 / US | [2017/13] |
| Former [2012/23] | 01 /
Eichmeyer, Mark BOEHRINGER INGELHEIM VETMEDICA, INC. 2621 North Belt Highway St. Joseph, MO 64506-2002 / US | ||
| 02 /
Nitzel, Greg BOEHRINGER INGELHEIM VETMEDICA, INC. 2621 North Belt Highway St. Joseph, MO 64506-2002 / US | |||
| 03 /
Schaeffer, Merrill BOEHRINGER INGELHEIM VETMEDICA, INC. 2621 North Belt Highway St. Joseph, MO 64506-2002 / US | Representative(s) | Hoffmann Eitle Patent- und Rechtsanwälte PartmbB Arabellastraße 30 81925 München / DE | [N/P] |
| Former [2017/13] | Hoffmann Eitle Patent- und Rechtsanwälte PartmbB Arabellastraße 30 81925 München / DE | ||
| Former [2012/23] | HOFFMANN EITLE Patent- und Rechtsanwälte Arabellastraße 4 81925 München / DE | Application number, filing date | 12155378.8 | 29.12.2005 | [2012/23] | Priority number, date | US20040640510P | 30.12.2004 Original published format: US 640510 P | US20050034797 | 13.01.2005 Original published format: US 34797 | US20050319975 | 29.12.2005 Original published format: US 319975 | [2012/23] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | EP2460817 | Date: | 06.06.2012 | Language: | EN | [2012/23] | Type: | A3 Search report | No.: | EP2460817 | Date: | 09.01.2013 | Language: | EN | [2013/02] | Type: | B1 Patent specification | No.: | EP2460817 | Date: | 29.03.2017 | Language: | EN | [2017/13] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 06.12.2012 | Classification | IPC: | C07K14/01, A61K39/12, C12N7/04, C12Q1/68, A61K39/295 | [2012/23] | CPC: |
A61K39/12 (EP,US);
C12N15/10 (KR);
A61K33/00 (EP,US);
A61K45/06 (EP,US);
A61P31/00 (EP);
A61P31/12 (EP);
A61P31/20 (EP);
A61P37/00 (EP);
A61P37/04 (EP);
C07K14/005 (EP,US);
C07K16/00 (KR);
C12N15/09 (KR);
C12N15/11 (KR);
A61K2039/5258 (EP,US);
A61K2039/545 (EP,US);
A61K2039/552 (EP,US);
A61K2039/55505 (EP,US);
A61K2039/55555 (EP,US);
C12N2710/14143 (EP,US);
C12N2710/14163 (EP,US);
C12N2750/10022 (EP,US);
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LI, LT, LU, LV, MC, NL, PL, PT, RO, SE, SI, SK, TR [2012/23] | Extension states | BA | 14.02.2012 | HR | 14.02.2012 | MK | 14.02.2012 | Title | German: | Immunogene PCV2-Zusammensetzungen und Verfahren zur Herstellung solcher Zusammensetzungen | [2012/23] | English: | PCV2 immunogenic compositions and methods of producing such compositions | [2012/23] | French: | Compositions immunogènes PCV2 et procédés de production de ces compositions | [2012/23] | Examination procedure | 14.02.2012 | Examination requested [2012/23] | 05.07.2013 | Amendment by applicant (claims and/or description) | 29.10.2013 | Despatch of a communication from the examining division (Time limit: M06) | 08.05.2014 | Reply to a communication from the examining division | 14.12.2016 | Communication of intention to grant the patent | 10.01.2017 | Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO | 02.02.2017 | Communication of intention to grant the patent | 13.02.2017 | Fee for grant paid | 13.02.2017 | Fee for publishing/printing paid | 13.02.2017 | Receipt of the translation of the claim(s) | 20.05.2020 | Observations by third parties | 08.07.2020 | Observations by third parties | Parent application(s) Tooltip | EP05856068.1 / EP1833992 | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20050856068) is 12.02.2010 | Opposition(s) | Opponent(s) | 01
22.12.2017
26.08.2019
WITHDRAWN Intervet International BV Wim de Körverstraat 35 5831 AN Boxmeer / NL | [2019/40] |
| Former [2018/06] | |||
| Opponent(s) | 01
22.12.2017
04.01.2018
ADMISSIBLE Intervet International BV Wim de Körverstraat 35 5831 AN Boxmeer / NL | 03.02.2002 | Legal effect of revocation of patent [2022/16] | 16.01.2018 | Invitation to proprietor to file observations on the notice of opposition | 25.05.2018 | Reply of patent proprietor to notice(s) of opposition | 10.05.2019 | Date of oral proceedings | 21.06.2019 | Despatch of minutes of oral proceedings | 21.06.2019 | Despatch of communication that the patent will be revoked | 03.02.2022 | Legal effect of revocation of patent [2022/42] | Appeal following opposition | 21.08.2019 | Appeal received No. T2353/19 | 31.10.2019 | Statement of grounds filed | 03.02.2022 | Result of appeal procedure: appeal of the proprietor was rejected | 14.03.2022 | Despatch of the decision of the Board of Appeal | 03.02.2022 | Date of oral proceedings | Fees paid | Renewal fee | 14.02.2012 | Renewal fee patent year 03 | 14.02.2012 | Renewal fee patent year 04 | 14.02.2012 | Renewal fee patent year 05 | 14.02.2012 | Renewal fee patent year 06 | 14.02.2012 | Renewal fee patent year 07 | 19.12.2012 | Renewal fee patent year 08 | 19.12.2013 | Renewal fee patent year 09 | 22.12.2014 | Renewal fee patent year 10 | 21.12.2015 | Renewal fee patent year 11 | 20.12.2016 | Renewal fee patent year 12 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [A]WO0001409 (MERIAL SAS [FR], et al) [A] 1-26 * examples 17, 18 *; | [A]WO0077216 (MERIAL SAS [FR]) [A] 1-26 * examples 6, 9 *; | [AP]WO2005009462 (MERIAL LTD [US], et al) [AP] 1-26 * example 7 *; | [E]WO2007028823 (INTERVET INT BV [NL], et al) [E] 1-7,11-13,16-24,26 * example 5 *; | [XI] - BLANCHARD P ET AL, "Protection of swine against post-weaning multisystemic wasting syndrome (PMWS) by porcine circovirus type 2 (PCV2) proteins", VACCINE, ELSEVIER LTD, GB, (20031107), vol. 21, no. 31, doi:10.1016/S0264-410X(03)00503-6, ISSN 0264-410X, pages 4565 - 4575, XP004467337 [X] 1-3,7,11-13,16-24,26 * figures 2-4 * * tables 1, 2 * * page 4574, column l, lines 11-14 * [I] 4-6,8,9,14,15,25 DOI: http://dx.doi.org/10.1016/S0264-410X(03)00503-6 | [A] - NAWAGITGUL P ET AL, "Open reading frame 2 of porcine circovirus type 2 encodes a major capsid protein", JOURNAL OF GENERAL VIROLOGY, SOCIETY FOR GENERAL MICROBIOLOGY, SPENCERS WOOD, GB, (20000101), vol. 81, no. 9, ISSN 0022-1317, pages 2281 - 2287, XP002978778 [A] 1-26 * the whole document * | [A] - KIM YUNA ET AL, "Characterization of the recombinant proteins of porcine circovirus type2 field isolate expressed in the baculovirus system", JOURNAL OF VETERINARY SCIENCE, KOREAN SOCIETY OF VETERINARY SCIENCE, SUWON, KR, (20020301), vol. 3, no. 1, ISSN 1229-845X, pages 19 - 23, XP002349036 [A] 1-26 * page 20, column R, paragraph 3 * * figure 4 * | [A] - RAGONA G ET AL, "The transcriptional factor Egr-1 is synthesized by baculovirus-infected insect cells in an active, DNA-binding form.", DNA AND CELL BIOLOGY 1991 JAN-FEB, (199101), vol. 10, no. 1, ISSN 1044-5498, pages 61 - 66, XP002557491 [A] 1-26 * page 65, column L, paragraph 2 * DOI: http://dx.doi.org/10.1089/dna.1991.10.61 | [T] - KIXMOLLER M ET AL, "Reduction of PMWS-associated clinical signs and co-infections by vaccination against PCV2", VACCINE, ELSEVIER LTD, GB, vol. 26, no. 27-28, doi:10.1016/J.VACCINE.2008.04.032, ISSN 0264-410X, (20080625), pages 3443 - 3451, (20080505), XP022710551 DOI: http://dx.doi.org/10.1016/j.vaccine.2008.04.032 | [T] - FACHINGER ET AL, "The effect of vaccination against porcine circovirus type 2 in pigs suffering from porcine respiratory disease complex", VACCINE, ELSEVIER LTD, GB, (20080301), vol. 26, no. 11, ISSN 0264-410X, pages 1488 - 1499, XP022505432 | by applicant | US2909462 | US6703023 | - JOURNAL OF GENERAL VIROLOGY, (2000), vol. 81, pages 2281 - 2287 | - HUNTER ET AL., The Theory and Practical Application of Adjuvants, JOHNWILEY AND SONS, (1995), pages 5L - 94 | - TODD ET AL., VACCINE, (1997), vol. 15, pages 564 - 570 | - M. POWELL AND M. NEWMAN, Vaccine Design, The Subunit and Adjuvant Approach, PLENUM PRESS, (1995), page 147 | - PHAMEUROPA, (199606), vol. 8, no. 2 | - CARILLO, H.; LIPMAN, D., SIAM J. APPLIED MATH., (1988), vol. 48, page 1073 | - DEVEREUX, J. ET AL., NUCLEIC ACIDS RESEARCH, (1984), vol. 12, no. 1, page 387 | - ALTSCHUL, S. F. ET AL., J. MOLEC. BIOL., (1990), vol. 215, pages 403 - 410 | - ALTSCHUL, S. ET AL., BLAST Manual, NCVI NLM NLH BETHESDA | US20050034797 | Opposition | US2002106639 | US2003170270 | US6703023 | US2004132178 | WO2005009462 | WO2006072065 | WO2007028823 | WO2008076915 | - KRAKOWKA et al., "Activation of the Immune System is the Pivotal Event in the Production of Wasting Disease in Pigs Infected with Porcine Circovirus-2 (PCV-2)", Vet Pathol, (20010000), vol. 38, pages 31 - 42, XP055277395 DOI: http://dx.doi.org/10.1354/vp.38-1-31 | - BLANCHARD et al., "Protection of swine against post-weaning multisystemic wasting syndrome (PMWS) by porcine circovirus type 2 (PCV2) proteins", Vaccine, (20030000), vol. 21, pages 4565 - 4575, XP004467337 DOI: http://dx.doi.org/10.1016/S0264-410X(03)00503-6 | - Rueda et al., "Effect of different baculovirus inactivation procedures on the integrity and immunogenicity of porcine parvovirus-like particles", Vaccine, (20010000), vol. 19, pages 726 - 734, XP004225389 DOI: http://dx.doi.org/10.1016/S0264-410X(00)00259-0 | - Pastoret et al., Veterinary Vaccinology, (19970000), pages 175, 177 - 178, XP055277388 |